Live Dana-Farber Cancer Institute News with Latest Updates

Live Dana-Farber Cancer Institute news and developments with the latest updates. Check out current Dana-Farber Cancer Institute news stories and find out what happened, what is going on with Dana-Farber Cancer Institute. Recent news updates about Dana-Farber Cancer Institute
Dana-Farber announces initiatives for Colorectal Cancer Awareness month in March
Break Through Cancer launches collaborative model across top U.S. research institutions in pursuit of cancer cures
Break Through Cancer launches collaborative model with MD Anderson, top U.S. research institutions
CAR T-cell therapy generates lasting remissions in patients with multiple myeloma
New recommendations aim to eliminate racial bias in myeloma trials
Dana-Farber, Broad Institute and Count Me In receive $16 million grant to launch patient-partnered research initiatives
Dana-Farber Cancer Institute Joins Caris’ Precision Oncology Alliance
Laurie H. Glimcher, MD, named to Modern Healthcare’s Women Leaders Luminaries list
Dana-Farber Medical Oncology Chair receives Sjöberg Prize for cancer research
Immunotherapy – targeted drug combination improves survival in advanced kidney cancer
Dana-Farber Cancer Institute and Deerfield Management Launch Riverway Discoveries
First mammography screening guidelines issued for older survivors of breast cancer
“Nuclear Physics”: Imaging into Heart of a Cell
Noninvasive blood test tracks organ injury from COVID-19
Dana-Farber to hold a discussion for cancer patients and survivors about Covid-19 vaccine
Dana-Farber Cancer Institute opens new state-of-the-art location in Chestnut Hill
Dana-Farber research supports FDA approval for immunotherapy combination in advanced kidney cancer
Personalized vaccine produces long-lasting anti-tumor response in patients with melanoma, study shows
Multidisciplinary research identifies novel targeted therapy for children with acute lymphoblastic leukemia
Biden taps Eric Lander and Maria Zuber for senior science posts
Study shows sharp decline in cancer screenings and diagnoses during first COVID-19 surge
Dana-Farber Cancer Institute launches investment fund to support startup companies
Study finds new evidence of health threat from chemicals in marijuana and tobacco smoke
Scientists create ON-OFF switches to control CAR T cell activity
Eric P. Winer elected ASCO President for term starting in June 2022
Breast cancer study uncovers how macrophages may contribute to a therapeutic weak spot
John Ryan named Senior Vice President and General Counsel at Dana-Farber Cancer Institute
National Academy of Inventors names Gordon Freeman a 2020 Fellow
Kimmie Ng, MD, MPH of Young-Onset Colorectal Cancer Center Receives Colorectal Cancer Alliance Grant for Microbiome
Adding checkpoint inhibitor to chemotherapy improves responses without negatively impacting quality of life
Dana-Farber Researcher awarded for review paper on racial disparities in survival in children with Acute
More than 30 research studies led by Dana-Farber faculty to be presented
Circulating tumor DNA indicates increased risk of relapse after stem cell transplant
Venetoclax added to standard treatments shows promise in high-risk myeloid blood cancers
Study reveals surprising benefit of clonal hematopoiesis in allogeneic transplants
Donor stem cell transplant shown to improve survival in older patients with myelodysplastic syndrome
New map provides scientists with head start on how to destroy cancer-related enzymes rather than just block them
Mortality rate after cancer surgery drops during 10-year period, but gap persists between Black and white patients
Native American ancestry associated with increased mutations
Dana-Farber to present more than 40 research studies at 2020 ASH Annual Meeting
Two Dana-Farber faculty members elected as Fellows of American Association for Advancement of Science
BICRA gene provides answers to patients, doctors and scientists
Dana-Farber Cancer Institute and Quest Diagnostics collaborate to identify prevalence of COVID-19
Dana-Farber Cancer Institute partners with Prostate Cancer Foundation to advance prostate cancer treatment for
Dana-Farber/Brigham and Women’s Cancer Center and Stamford Hospital announce expanded collaboration
Dana-Farber Cancer Institute at top of 2020 Top 100 Women-Led Businesses in Massachusetts
Medicaid expansion linked to lower mortality rates for three major types of cancer
Experts release new management strategies for malignant colorectal polyps